Multiple myeloma is an incurable cancer of the bone marrow that is dependent on its microenvironment, including bone marrow adipocytes (BMAds). Here, we discuss our findings that the reciprocal interaction of myeloma cells and BMAds, leads to myeloma cell survival and induces metabolic dysfunction and senescence-associated secretory phenotype in BMAds.
Subscribe to Journal
Get full journal access for 1 year
only $4.96 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Croucher, P. I., McDonald, M. M. & Martin, T. J. Bone metastasis: the importance of the neighbourhood. Nat. Rev. Cancer 16, 373–386 (2016).
Reagan, M. R., Fairfield, H. & Rosen, C. J. Bone marrow adipocytes: a link between obesity and bone cancer. Cancers (Basel) 13, 364 (2021).
Caers, J., Deleu, S., Belaid, Z., De Raeve, H., Van Valckenborgh, E., De Bruyne, E. et al. Neighboring adipocytes participate in the bone marrow microenvironment of multiple myeloma cells. Leukemia 21, 1580–1584 (2007).
Liu, Z., Xu, J., He, J., Liu, H., Lin, P., Wan, X. et al. Mature adipocytes in bone marrow protect myeloma cells against chemotherapy through autophagy activation. Oncotarget 6, 34329–34341 (2015).
Fairfield, H., Dudakovic, A., Khatib, C. M., Farrell, M., Costa, S., Falank, C. et al. Myeloma-modified adipocytes exhibit metabolic dysfunction and a senescence-associated secretory phenotype. Cancer Res. 81, 634–647 (2021).
Morris, E. V., Suchacki, K. J., Hocking, J., Cartwright, R., Sowman, A., Gamez, B. et al. Myeloma cells down-regulate adiponectin in bone marrow adipocytes via TNF-alpha. J. Bone Miner. Res. 35, 942–955 (2019).
Liu, H., He, J., Koh, S. P., Zhong, Y., Liu, Z., Wang, Z. et al. Reprogrammed marrow adipocytes contribute to myeloma-induced bone disease. Sci. Transl. Med. 11, eaau9087 (2019).
Lu, W., Weng, W., Zhu, Q., Zhai, Y., Wan, Y., Liu, H. et al. Small bone marrow adipocytes predict poor prognosis in acute myeloid leukaemia. Haematologica 103, e21–e24 (2018).
Yang, S., Lu, W., Zhao, C., Zhai, Y., Wei, Y., Liu, J. et al. Leukemia cells remodel marrow adipocytes via TRPV4-dependent lipolysis. Haematologica 105, 2572–2583 (2019).
Reagan, M. R., Mishima, Y., Glavey, S. V., Zhang, Y. Y., Manier, S., Lu, Z. N. et al. Investigating osteogenic differentiation in multiple myeloma using a novel 3D bone marrow niche model. Blood 124, 3250–3259 (2014).
Fairfield, H., Costa, S., Falank, C., Farrell, M., Murphy, C., D’Amico, A. et al. Multiple myeloma cells alter adipogenesis, increase senescence-related and inflammatory gene transcript expression, and alter metabolism in preadipocytes. Front. Oncol. 10, 584683 (2021).
Ethical approval and consent to participate
Consent to publish
All results and patient data referenced in this study have been included in the manuscript described by this commentary.
The authors declare no competing interests. The Reagan lab receives support from Oncopeptides to conduct research not related to this publication.
T.L.A. had received funding from the Region of Southern Denmark (20/14282). M.R.R. had received funding from the American Cancer Society (Research Grant #RSG-19-037-01-LIB), the NIH (U54GM115516, R01AR049069, R37CA245330, and P20GM121301) and the Kane Foundation.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Jafari, A., Fairfield, H., Andersen, T.L. et al. Myeloma-bone marrow adipocyte axis in tumour survival and treatment response. Br J Cancer 125, 775–777 (2021). https://doi.org/10.1038/s41416-021-01371-4